This activation is promoted in the presence of various nitric oxide synthetase enzymes (NOS), that is, inducible NOS (iNOS)/endothelial NOS (eNOS) at HCC sites (Bonavida and Garban, 2015). This evidence concerns the gene NOS2 and hepatocellular carcinoma.